IMA Medical Group Significantly Expands Partnership With MedAvail, Providing Integrated SpotRx Pharmacy Experience
06 January 2022 - 12:00AM
Business Wire
Innovative self-serve pharmacy kiosks to be
embedded in 17 additional locations across Central Florida
MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a
technology-enabled pharmacy company, today announced that it has
significantly expanded its partnership with IMA Medical Group, a
provider of high quality primary medical and wellness services to
seniors, with plans to open 17 additional SpotRx locations across
central Florida.
In-clinic SpotRx kiosks and courier home delivery are expected
to be available to patients across the IMA network in 21 IMA
medical centers, including the four SpotRx locations previously
announced in September. MedAvail plans to leverage its pharmacy hub
in Orlando to deploy and service SpotRx kiosks to these medical
centers and expects to complete deployment to these locations by
early 2022. SpotRx Pharmacy is the retail pharmacy brand owned and
operated by MedAvail in the United States, which deploys and
operates the MedAvail MedCenters.
“We are excited to be expanding our partnership with IMA and
broadening the convenience of our transformative pharmacy services
to Medicare patients in Florida,” said Ed Kilroy, Chief Executive
Officer of MedAvail. “We deployed five of the additional 17 medical
centers announced today in the fourth quarter of 2021, with the
balance expected to be installed in early 2022.”
MedAvail’s SpotRx Pharmacy business is primarily focused on the
Medicare (65+ year old) market and the medical clinics where they
receive care. The SpotRx MedCenter allows patients to virtually
consult with a pharmacist and fill their medications within
clinics, eliminating the need to visit a pharmacy. SpotRx also
provides patients the option to have their medications delivered to
their homes free of charge.
“After experiencing firsthand, the impactful difference our
patients had with SpotRx embedded pharmacies in our clinics, we
knew right away that SpotRx needed to be an integral part of our
medical centers,” said Dr. Mark Leenay, Chief Executive Officer of
IMA Medical Group. “We are thrilled to be able to offer this
differentiated solution in all of our clinics and further our
efforts in providing our patients with the highest standard of
care.”
About IMA Medical Group
IMA Medical Group provides high quality primary medical and
wellness services focusing on improving patient care, reducing
costs, and offering convenient services for patients, their
families and caregivers. Headquartered in Orlando, Florida, IMA
serves patients in 23 medical centers across Central Florida
including Orlando, Lakeland, Davenport, Winter Haven, Lake Wales,
Clermont, Oviedo, Kissimmee, St. Cloud, Debary, Tampa, and Town N
Country, where over 70 physicians and nurse practitioners provide
comprehensive medical services to over 40,000 members in
partnership with all leading Medicare Health Plans. For more
information, please visit www.imamedicalgroup.com.
About SpotRx
SpotRx places control of the pharmacy experience back in the
hands of consumers. SpotRx is a telehealth platform that delivers
remote pharmacist consultations through an on-site dispensing
kiosk, supplemented with home delivery capability.
About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled
pharmacy organization, providing turnkey in-clinic pharmacy
services through its proprietary robotic dispensing platform, the
MedAvail MedCenter, and home delivery operations, to Medicare
clinics. MedAvail helps patients to optimize drug adherence,
resulting in better health outcomes. Learn more at
www.medavail.com.
SOURCE MedAvail Holdings Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220105005452/en/
Investor Relations Caroline Paul Gilmartin Group
ir@medavail.com
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jun 2024 to Jul 2024
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jul 2023 to Jul 2024